Monograph Title | Section | Source Publication | Page Number Sort descending | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
POWDERED ROSEMARY | COMPOSITION/Content of Phenolic Diterpenes | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Before injection, pass through a membrane filter of 0.45-µL or finer pore size, to: Before injection, pass through a membrane filter of 0.45-µm or finer pore size, |
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER | IDENTIFICATION/A. | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | Change USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS to: USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer Type C RS) |
AZITHROMYCIN | CHEMICAL INFORMATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | Change 748.98 to: 749.00 AND Change 767.00 to: 767.01 AND Change 785.02 to: 785.03 |
CEFDINIR CAPSULES | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 AND In USP Reference Standards 〈11〉/USP Cefdinir Related Compound B RS: Change C14H13N4O4S… Read More |
MILK THISTLE CAPSULES | PERFORMANCE TESTS/Disintegration and Dissolution <2040>, Dissolution | USPNF Online | Online | 24-Jun-2022 | 1-Aug-2022 | NA | NA | In Medium: Change Buffer containing 2% lauryl sulfate; 900 mL to: Buffer containing 2% sodium lauryl sulfate; 900 mL |
METHYLENE BLUE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Azure B RS: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |
PENICILLIN G BENZATHINE INJECTABLE SUSPENSION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | Change It responds to the Identification test under Penicillin G Benzathine Oral Suspension. to: Mix a portion of it with methanol to obtain a solution containing about 3000 Penicillin G Units per mL. Apply 20 µL of this test solution and… Read More |
METAPROTERENOL SULFATE ORAL SOLUTION | Identification/A. | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed as directed in Identification test A under Metaproterenol Sulfate Inhalation Solution, beginning with “Allow the spots to dry”: to: Allow the spots to dry, and develop the chromatogram in a solvent system consisting… Read More |
ESCITALOPRAM TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Buffer: Change Adjust with 1 N sodium hydroxide VS to a pH of 5.2. to: Adjust with 1 N sodium hydroxide to a pH of 5.2. |
TRIMETHOBENZAMIDE HYDROCHLORIDE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | Change N-[p-[2-(Dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxy benzamide monohydrochloride to: N-[4-[2-(Dimethylamino)ethoxy]benzyl]-3,4,5-trimethoxybenzamide monohydrochloride |
OIL- AND WATER-SOLUBLE VITAMINS WITH MINERALS CAPSULES | STRENGTH | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Vitamin A, Method 3/Analysis: Change CS = concentration of retinyl acetate (C23H32O2) from USP Vitamin A RS in the Standard solution (μg/mL) to: CS = concentration… Read More |
COCOYL CAPRYLOCAPRATE | SPECIFIC TESTS | USPNF Online | Online | 23-Feb-2024 | 1-May-2024 | NA | NA | In Fats and Fixed Oils 〈401〉, Procedures, Hydroxyl Value/Analysis: Change Calculate the acid value as directed in the chapter. to: Calculate the hydroxyl value as directed in the chapter. |
CARBAMAZEPINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Carbamazepine Related Compound A RS: Change 238.28 to: 238.29 AND In USP Carbamazepine Related Compound B RS: Change 193.24 to: 193.25 AND In USP 9-Methylacridine RS: Change 193.24 to: 193.25 |
METHOTREXATE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Methotrexate System Suitability Mixture RS: Change C22H26N8O5 · HCl 518.95 to: C22H26N8O5 · xHCl |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
MESO-ZEAXANTHIN PREPARATION | COMPOSITION/Stereoisomeric Composition | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In System suitability: Change [Note—The approximate relative retention times for (3S,3′S)-zeaxanthin, (3R,3′S-meso)-zeaxanthin, (3R,3′R)-zeaxanthin, and (3R,3′R,6′R)-lutein are 0.94… Read More |
<209> LOW MOLECULAR WEIGHT HEPARIN MOLECULAR WEIGHT DETERMINATIONS | PROCEDURE | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In footnote 1 in Molecular Weight Measurements of Low Molecular Weight Heparins by Gel Permeation Chromatography/Chromatographic system/Columns/Analytical: Change guard column TSK SWXL 6-mm × 4-mm; to: guard column TSK… Read More |
METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | In USP Methylphenidate Related Compound A RS: Change α-Phenyl-2-piperidineacetic acid hydrochloride. to: (RS)-2-Phenyl-2-[(RS)-piperidin-2-yl]acetic acid hydrochloride. |
CRANBERRY FRUIT DRY JUICE | DEFINITION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | Change procyanidin A2 to: procyanidin A2 |
DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉: Move Test 2 after Test 1 |
SUCROSE | IMPURITIES | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Sulfite/Analysis/footnote 1: Change Test kit for sulfite determination may be ordered from the following suppliers: Megazyme Ltd. (Product code: K-ETSULPH); R-Biopharm (Enzytec) (Article No.: E6275); BioSenTec/Nzytech (Catalogue No.: AK00071).… Read More |
IBUPROFEN ORAL SUSPENSION | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Analysis: Change Result = (RU/RS) x CS x V x (D/WU) x (1/L) x 100 RU = peak area ratio of ibuprofen to benzophenone from the … Read More |
DACARBAZINE FOR INJECTION | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Suitability requirements/Signal-to-noise ratio: Change NTL 10, to: NLT 10, |
DIAZOXIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In footnote a in Table 2: Change 7-Chloro-2H-benzothiadiazin-3(4H)-one 1,1-dioxide. to: 7-Chloro-2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxide. |
<251> LEAD | REQUIREMENTS FOR PROCEDURE VALIDATION | USPNF Online | Online | 27-Jan-2023 | 1-Jun-2023 | NA | NA | Change • Precision Repeatability to: • Precision |
ROSEMARY LEAF DRY AQUEOUS EXTRACT | COMPOSITION/Content of Rosmarinic Acid | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Standard solution B: Change Before injection, pass through a membrane filter of 0.45-µL or finer pore size, to: Before injection, pass through a membrane filter of 0.45-µm or finer pore size, AND In Sample solution: Change … Read More |
CALCIUM ASCORBATE | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Aug-2023 | NA | NA | In Analysis: Change Mr1 = molecular weight of calcium ascorbate dihydrate, 426.43 to: Mr1 = molecular weight of calcium ascorbate dihydrate, 426.34 |
AZITHROMYCIN | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Table 2: Change: 3′-N-{[4-(Acetylamino)phenyl]sulfonyl}-3′-demethylazithromycinm to: 3’-N-Demethyl-3’-N-[(4-methylphenyl)sulfonyl]azithromycinm AND In Organic Impurities… Read More |
CEFDINIR FOR ORAL SUSPENSION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 AND In USP Reference Standards 〈11〉/USP Cefdinir Related Compound B RS: Change C14H13N4O4S… Read More |
MILK THISTLE TABLETS | PERFORMANCE TESTS/Disintegration and Dissolution <2040>, Dissolution | USPNF Online | Online | 24-Jun-2022 | 1-Aug-2022 | NA | NA | In Medium: Change Buffer containing 2% lauryl sulfate; 900 mL to: Buffer containing 2% sodium lauryl sulfate; 900 mL |
ECONAZOLE NITRATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In USP Econazole Related Compound C RS: Change 1-(4-Chlorobenzyl)-3-{2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazol-3-ium nitrate (salt). C25H21Cl14N3O4 569.… Read More |
PENICILLIN G BENZATHINE AND PENICILLIN G PROCAINE INJECTABLE SUSPENSION | IDENTIFICATION | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Test A: Change It responds to the Identification test under Penicillin G Benzathine Oral Suspension: the spot obtained from the test solution, corresponding in RF value to that obtained from the Standard solution, is… Read More |
TRIETHYL CITRATE | ASSAY/Procedure | USPNF Online | Online | 24-Feb-2023 | 1-May-2023 | NA | NA | In System suitability/Suitability requirements/Tailing factor: Change NMT 1.5 for the triethyl citrate to trimethyl citrate peaks to: NMT 1.5 for the triethyl citrate and trimethyl citrate peaks |
ESCITALOPRAM TABLETS | PERFORMANCE TESTS/Dissolution 〈711〉 | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Test 1/Medium: Change 0.1 N hydrochloric acid VS; 900 mL to: 0.1 N hydrochloric acid; 900 mL AND In Test 2/Medium: Change 0.1 N hydrochloric acid VS; 900 mL to: 0.1 N hydrochloric acid; 900 mL |
AZITHROMYCIN FOR INJECTION | IMPURITIES | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | USPNF 2024 Issue 2 | In footnote m in Table 2: Change (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-… Read More |
OIL-SOLUBLE VITAMINS CAPSULES | STRENGTH | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Vitamin A, Method 3/Analysis: Change CS = concentration of retinyl acetate (C23H32O2) from USP Vitamin A RS in the Standard solution (μg/mL) to: CS = concentration… Read More |
FLURAZEPAM HYDROCHLORIDE | USP REFERENCE STANDARDS 〈11〉 | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In USP Flurazepam Related Compound C RS: Change 5-Chloro-2-(2-diethylaminoethyl(amino)-2′-fluorobenzophenone hydrochloride. to: 5-Chloro-2-(2-diethylaminoethylamino)-2′-fluorobenzophenone hydrochloride. |
FLUOCINOLONE ACETONIDE | Organic Impurities | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Acceptance criteria/Total impurities: Change NMT 2.5%. Disregard any peak below 0.05% of the peak area of fluocinolone acetonide from the Standard solution. to: NMT 2.5%. Disregard any peak below 0.05% of the peak area of… Read More |
TRYPTOPHAN | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Tryptophan Related Compound A RS: Change 3,3′-[Ethylidenebis(1H-indole-1,3-diyl)]bis[2S)-2-aminopropanoic]acid. C24H26N4O4 432.49 to: (2S,2'S)-3,3'-[Ethane-1,1-diylbis(1H-… Read More |
TETRACYCLINE HYDROCHLORIDE | SPECIFIC TESTS/Bacterial Endotoxins Test <85> | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change Where the label states tetracycline hydrochloride must be subjected to further processing during the preparation of injectable dosage forms, the level of bacterial endotoxins are such that the requirement under the relevant dosage form monograph(s) in… Read More |
MESO-ZEAXANTHIN PREPARATION | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In USP meso-Zeaxanthin RS: Change (3R,3′S-meso)-Zeaxanthin. to: (3R,3′S)-Zeaxanthin. |
DEXTRATES | ASSAY/Dextrose Equivalent | USPNF Online | Online | 31-Mar-2023 | 1-May-2023 | NA | NA | In Analysis: Change rA = peak response of each saccharide degree of polymerization (DP1–DP3) in the Sample solution (If any peaks of DP4 and above are observed in the sample, take the summation… Read More |
ATORVASTATIN CALCIUM | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | Change USP Atorvastatin Related Compound H RS (lactone impurity) to: USP Atorvastatin Related Compound H RS Also known as Lactone impurity; AND Change USP Atorvastatin Related Compound I RS (acetonide impurity) to: USP Atorvastatin Related… Read More |
CRANBERRY FRUIT DRY JUICE | IDENTIFICATION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In A./Standard solution B: Change USP Procyanidin A2 RS to: USP Procyanidin A2 RS AND In A./System suitability/Suitability requirements/Derivatization reagent B/White light… Read More |
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Dissolution 〈711〉/Test for dutasteride/Tier 2/Medium: Change 10 g/L of cetyltrimethylammonium bromide and 750,000 USP units of activity/mg of pepsin, purified in 0.1 N hydrochloric acid; 900 mL to: Dissolve 10 g of… Read More |
<1228.1> DRY HEAT DEPYROGENATION | INTRODUCTION | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | Change parental manufacturing to: parenteral manufacturing |
ATRACURIUM BESYLATE | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimeth oxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate, pentamethylene ester to: 2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium benzenesulfonate,… Read More |
IRINOTECAN HYDROCHLORIDE INJECTION | DEFINITION | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change NTL 90.0% and NMT 110.0% to: NLT 90.0% and NMT 110.0% |
DOXAZOSIN MESYLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of the corresponding USP Doxazosin Related Compound RS or USP Doxazosin Mesylate RS (for calculating unspecified impurities) in the Standard solution (mg/mL) to: CS… Read More |
ISOBUTYL ALCOHOL | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Analysis: Change rS = sum of all the peaks except those each of which with an area less than 0.1 times the area of the major peak from the Reference solution to: rT = sum of all the peaks except those… Read More |